Skip to main content
. Author manuscript; available in PMC: 2021 Jun 30.
Published in final edited form as: Paediatr Int Child Health. 2020 Dec 11;41(1):65–75. doi: 10.1080/20469047.2020.1853350

Table 4.

Key priorities of a paediatric-focused agenda to address emerging resistance of TB, HIV and gram-negative pathogens.

Priorities
Ensure equitable access to and development of infectious diagnostics.
Develop and expand antimicrobial stewardship in inpatient and community settings in low-, middle- and high-income countries.
Support and expand infection prevention and control strategies for clinic and hospital sites.
Improve recognition and management of resistant infections.
Study and implement child- and adolescent-centred care models for managing infections such as HIV and TB.
Increase access to research, including clinical trials of new treatment regimens and strategies, for children, adolescents and pregnant women.
Ensure an antimicrobial pipeline for novel treatment of resistant infections.
Support global public health agendas to tackle resistant infections in children and adolescents.